Prednisolone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
Condition:   Follicular Lymphoma (FL) Interventions:   Biological: Tisagenlecleucel;   Drug: Lenalidomide and rituximab (R2) in 28-day cycles for up to 12 cycles.;   Drug: Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or prednisolone (R-CHOP) in 21-day cycles for 6 to 8 cycles;   Drug: Lymphodepleting chemotherapy;   Ot her: Corticosteroids and/or Radiation (Bridging therapy) Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials